{
    "organizations": [],
    "uuid": "166de5ae4bac94bf5d48eb2e82c2c60ed76cdb73",
    "author": "",
    "url": "https://www.reuters.com/article/brief-actinium-pharmaceuticals-issues-le/brief-actinium-pharmaceuticals-issues-letter-to-investors-on-company-update-and-outlook-for-2018-idUSASB0C2C1",
    "ord_in_thread": 0,
    "title": "BRIEF-Actinium Pharmaceuticals Issues Letter To Investors On Company Update And Outlook For 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 25, 2018 / 1:51 PM / in 29 minutes BRIEF-Actinium Pharmaceuticals Issues Letter To Investors On Company Update And Outlook For 2018 Reuters Staff 1 Min Read \nJan 25 (Reuters) - Actinium Pharmaceuticals Inc: \n* ACTINIUM PHARMACEUTICALS ISSUES LETTER TO INVESTORS PROVIDING COMPANY UPDATE AND OUTLOOK FOR 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-01-25T15:51:00.000+02:00",
    "crawled": "2018-01-25T16:22:56.040+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "pharmaceutical",
        "issue",
        "letter",
        "investor",
        "company",
        "update",
        "outlook",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "actinium",
        "pharmaceutical",
        "inc",
        "actinium",
        "pharmaceutical",
        "issue",
        "letter",
        "investor",
        "providing",
        "company",
        "update",
        "outlook",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}